These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10350665)

  • 21. Non-inferiority trials: the 'at least as good as' criterion.
    Laster LL; Johnson MF
    Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole.
    Loscalzo J
    Circulation; 2005 Nov; 112(20):3026-9. PubMed ID: 16286598
    [No Abstract]   [Full Text] [Related]  

  • 23. Stopping rules for clinical trials incorporating clinical opinion.
    Freedman LS; Lowe D; Macaskill P
    Biometrics; 1984 Sep; 40(3):575-86. PubMed ID: 6518241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Planned equivalence or noninferiority trials versus unplanned noninferiority claims: are they equal?
    Zee BC
    J Clin Oncol; 2006 Mar; 24(7):1026-8. PubMed ID: 16505420
    [No Abstract]   [Full Text] [Related]  

  • 26. [Superiority, equivalence and not inferiority studies for clinical trials].
    Attanasio E
    Prof Inferm; 2006; 59(1):49-57. PubMed ID: 16824361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Equivalence and non-inferiority trials].
    Lange S; Bender R; Ziegler A
    Dtsch Med Wochenschr; 2007; 132 Suppl 1():e53-6. PubMed ID: 17530600
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic equivalence: fallacies and falsification.
    Garrett AD
    Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther M; Bates SM; Ginsberg JS
    Can J Clin Pharmacol; 2005; 12(3):e229-39. PubMed ID: 16278495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Equivalence trials in SLE research: issues to consider.
    Kim MY; Buyon JP; Petri M; Skovron ML; Shore RE
    Lupus; 1999; 8(8):620-6. PubMed ID: 10568898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded confidence intervals, one-sided tests, and equivalence testing.
    Bofinger E
    J Biopharm Stat; 1992; 2(2):181-8. PubMed ID: 1300212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Practical examples: trials and conclusions -- an interactive segment.
    Talley NJ
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():9-13; discussion 38-9. PubMed ID: 15456458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating statistical difference, equivalence, and indeterminacy using inferential confidence intervals: an integrated alternative method of conducting null hypothesis statistical tests.
    Tryon WW
    Psychol Methods; 2001 Dec; 6(4):371-86. PubMed ID: 11778678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of testing times and critical values in sequential equivalence testing.
    Müller HH; Schäfer H
    Stat Med; 1999 Jul; 18(14):1769-88; discussion 1789. PubMed ID: 10407247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Equivalence approaches.
    Williams RL; Chen ML; Hauck WW
    Clin Pharmacol Ther; 2002 Sep; 72(3):229-37. PubMed ID: 12235443
    [No Abstract]   [Full Text] [Related]  

  • 38. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Equivalence concepts in clinical trials.
    Steinijans VW; Neuhäuser M; Bretz F
    Eur J Drug Metab Pharmacokinet; 2000; 25(1):38-40. PubMed ID: 11032089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methodology for superiority versus equivalence and non-inferior clinical studies. A practical review].
    Rosas-Peralta M; Santos-Martínez LE; Magaña-Serrano JA; Valencia-Sánchez JS; Garrido-Garduño M; Pérez-Rodríguez G
    Rev Med Inst Mex Seguro Soc; 2016; 54(3):344-53. PubMed ID: 27100981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.